Press of Atlantic City 26 months ago

J&J, Wyeth, others pull infant cold medications over safety

WASHINGTON (AP) - Drug makers on Thursday voluntarily pulled kids' cold medicines off the market less than two weeks after the government warned of potential health risks to infants. Full Article at Press of Atlantic City

Related Topics:

  1. Consumer Healthcare Products Association
  2. Food and Drug Administration
  3. Johnson & Johnson

Related Articles

  1. ParentDish logo
    Infant cold medicines being withdrawn
    26 months ago

    Filed under: Health and Safety, 0-3 months, Infant / First year, 12-18 months, 18-24 months, 2 years, Doctor's office, RecallsCiting "rare patterns of misuse", 14 different over-the-counter infant cough and cold medicines are being taken off store... Full Article at ParentDish

  2. Infant medicines pulled from shelves
    26 months ago

    Safety concerns involving overdoses prompted leading manufacturers to halt sales of over-the-counter infant cold and cough medicines, the companies announced yesterday. Full Article at Washington Times

  3. eMaxHealth logo
    CVS Pharmacy Recalls OTC Infant Cough And Cold Products
    26 months ago

    CVS / pharmacy is removing oral over-the-counter (OTC) infant cough and cold medicines from its stores as part of the Consumer Healthcare Products Association's (CHPA) voluntary withdrawal of these products. Full Article at eMaxHealth

  4. Reuters.co.uk logo
    Infant cough/cold medicines recalled
    26 months ago

    CHICAGO (Reuters) - Johnson & Johnson, Wyeth and other makers of infants' nonprescription cough and cold products are recalling certain medicines in the United States because of the danger of overdose, the Consumer Healthcare Products Association... Full Article at Reuters.co.uk

View all Related Articles »

Related Quotes

  1. The health and safety of our customers and their children is our highest priority
    SOURCE: eMaxHealth 26 months ago
  2. We know that the majority of children with coughs and colds have viral infections and there's really not much we can do to treat those infections.
    SOURCE: CBC News 26 months ago
  3. At this point, the studies that have been done show no benefit and we do have reported, although rare, bad outcomes
    SOURCE: Reuters Alert Net 26 months ago
  4. What you want to do for an infant is use saline drops
    SOURCE: KLTV 26 months ago
View all Related Quotes »
(What's this?)
  1. Are you a Publisher?

    We built Daylife.com using our SmartMedia Services platform, which can give you thousands of content-rich, advertiser-friendly pages (like this one) on any topic and with full editorial control. Learn More »

    Our Customers
    prev
    next
  2. Our Products
    Daylife Select

    A point & click tool to create dynamic content portals. Learn More »

  3. Daylife API

    Unlimited smart, customizable content to suit any publisher. Learn More »

  4. Enterprise API

    Use the Daylife Platform to distribute content across your sites. Learn More »

  5. SmartContext

    Weave the web's best content into your own. Learn More »

Browse More Photos

Daylife is the web's largest archive of news photos

  1. St. Jude Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) approval and U.S. market introduction of its new Penta(TM) surgical lead for neurostimulation therapy.
  2. SEOUL, SOUTH KOREA - OCTOBER 27: Medical workers of the Korea University Hospital wait for vaccination of H1N1 swine flu vaccine at Korea University Hospital on October 27, 2009 in Seoul, South Korea.
  3. WASHINGTON - SEPTEMBER 29: Senate Judiciary Committee's Crime and Drugs Subcommittee Chairman Arlen Specter (D-PA) delivers an opening statement during a hearing on 'Body Building Products and Hidden Steroids: Enforcement Barriers' on Capitol Hill September 29, 2009 in Washington, DC.

Cast of Characters

  1. Consumer Healthcare Products Association
  2. Food and Drug Administration Food and Drug Administration
  3. Johnson & Johnson Johnson & Johnson
  4. Novartis Novartis